Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens

Persistent infection with high-risk human papilloma viruses (HPV) is the worldwide cause of many cancers, including cervical, anal, vulval, vaginal, penile and oropharyngeal. Since T cells naturally eliminate the majority of chronic HPV infections by recognizing epitopes displayed on virally altere...

Full description

Bibliographic Details
Main Authors: Derin B Keskin, Bruce eReinhold, Sun Young eLee, Guanglan eZhang, Simon eLank, David eO'Connor, Ross S Berkowitz, Vladimir eBrusic, Seung Jo eKim, Ellis L Reinherz
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2011.00075/full
_version_ 1811193357286768640
author Derin B Keskin
Derin B Keskin
Bruce eReinhold
Bruce eReinhold
Sun Young eLee
Guanglan eZhang
Guanglan eZhang
Simon eLank
David eO'Connor
Ross S Berkowitz
Vladimir eBrusic
Vladimir eBrusic
Seung Jo eKim
Ellis L Reinherz
Ellis L Reinherz
author_facet Derin B Keskin
Derin B Keskin
Bruce eReinhold
Bruce eReinhold
Sun Young eLee
Guanglan eZhang
Guanglan eZhang
Simon eLank
David eO'Connor
Ross S Berkowitz
Vladimir eBrusic
Vladimir eBrusic
Seung Jo eKim
Ellis L Reinherz
Ellis L Reinherz
author_sort Derin B Keskin
collection DOAJ
description Persistent infection with high-risk human papilloma viruses (HPV) is the worldwide cause of many cancers, including cervical, anal, vulval, vaginal, penile and oropharyngeal. Since T cells naturally eliminate the majority of chronic HPV infections by recognizing epitopes displayed on virally altered epithelium, we exploited Poisson detection mass spectrometry (MS3) to identify those epitopes and inform future T cell-based vaccine design. Nine cervical cancer biopsies from HPV-16 positive HLA-A*02 patients were obtained, histopathology determined, and E7 oncogene PCR-amplified from tumor DNA and sequenced. Conservation of E7 oncogene coding segments was found in all tumors. MS3 analysis of HLA-A*02 immunoprecipitates detected E711-19 peptide (YMLDLQPET) in seven of the nine tumor biopsies. The remaining two samples were E711-19 negative and lacked the HLA-A*02 binding GILT thioreductase peptide despite possessing binding-competent HLA-A*02 alleles. Thus, the conserved E711-19 peptide is a dominant HLA-A*02 binding tumor antigen in HPV-16 transformed cervical squamous and adenocarcinomas. Findings that a minority of HLA-A*02:01 tumors lack expression of both E711-19 and a peptide from a thioreductase important in processing of cysteine-rich proteins like E7 underscore the value of physical detection, define a potential additional tumor escape mechanism and have implications for therapeutic cancer vaccine development.
first_indexed 2024-04-12T00:07:01Z
format Article
id doaj.art-429b57706f1b45fa98a65a904b602c7b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T00:07:01Z
publishDate 2011-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-429b57706f1b45fa98a65a904b602c7b2022-12-22T03:56:04ZengFrontiers Media S.A.Frontiers in Immunology1664-32242011-12-01210.3389/fimmu.2011.0007517277Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimensDerin B Keskin0Derin B Keskin1Bruce eReinhold2Bruce eReinhold3Sun Young eLee4Guanglan eZhang5Guanglan eZhang6Simon eLank7David eO'Connor8Ross S Berkowitz9Vladimir eBrusic10Vladimir eBrusic11Seung Jo eKim12Ellis L Reinherz13Ellis L Reinherz14Dana-Farber Cancer InstituteHarvard Medical SchoolDana-Farber Cancer InstituteHarvard Medical SchoolCHA UniversityDana-Farber Cancer InstituteHarvard Medical SchoolUniversity of Wisconsin-MadisonUniversity of Wisconsin-MadisonBrigham and Women's HospitalDana-Farber Cancer InstituteHarvard Medical SchoolCHA UniversityDana-Farber Cancer InstituteHarvard Medical SchoolPersistent infection with high-risk human papilloma viruses (HPV) is the worldwide cause of many cancers, including cervical, anal, vulval, vaginal, penile and oropharyngeal. Since T cells naturally eliminate the majority of chronic HPV infections by recognizing epitopes displayed on virally altered epithelium, we exploited Poisson detection mass spectrometry (MS3) to identify those epitopes and inform future T cell-based vaccine design. Nine cervical cancer biopsies from HPV-16 positive HLA-A*02 patients were obtained, histopathology determined, and E7 oncogene PCR-amplified from tumor DNA and sequenced. Conservation of E7 oncogene coding segments was found in all tumors. MS3 analysis of HLA-A*02 immunoprecipitates detected E711-19 peptide (YMLDLQPET) in seven of the nine tumor biopsies. The remaining two samples were E711-19 negative and lacked the HLA-A*02 binding GILT thioreductase peptide despite possessing binding-competent HLA-A*02 alleles. Thus, the conserved E711-19 peptide is a dominant HLA-A*02 binding tumor antigen in HPV-16 transformed cervical squamous and adenocarcinomas. Findings that a minority of HLA-A*02:01 tumors lack expression of both E711-19 and a peptide from a thioreductase important in processing of cysteine-rich proteins like E7 underscore the value of physical detection, define a potential additional tumor escape mechanism and have implications for therapeutic cancer vaccine development.http://journal.frontiersin.org/Journal/10.3389/fimmu.2011.00075/fullMass SpectrometryHuman Papilloma VirusTumor antigensCTL targetsE7GILT
spellingShingle Derin B Keskin
Derin B Keskin
Bruce eReinhold
Bruce eReinhold
Sun Young eLee
Guanglan eZhang
Guanglan eZhang
Simon eLank
David eO'Connor
Ross S Berkowitz
Vladimir eBrusic
Vladimir eBrusic
Seung Jo eKim
Ellis L Reinherz
Ellis L Reinherz
Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
Frontiers in Immunology
Mass Spectrometry
Human Papilloma Virus
Tumor antigens
CTL targets
E7
GILT
title Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
title_full Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
title_fullStr Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
title_full_unstemmed Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
title_short Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
title_sort direct identification of an hpv 16 tumor antigen from cervical cancer biopsy specimens
topic Mass Spectrometry
Human Papilloma Virus
Tumor antigens
CTL targets
E7
GILT
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2011.00075/full
work_keys_str_mv AT derinbkeskin directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT derinbkeskin directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT bruceereinhold directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT bruceereinhold directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT sunyoungelee directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT guanglanezhang directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT guanglanezhang directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT simonelank directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT davideoconnor directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT rosssberkowitz directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT vladimirebrusic directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT vladimirebrusic directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT seungjoekim directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT ellislreinherz directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens
AT ellislreinherz directidentificationofanhpv16tumorantigenfromcervicalcancerbiopsyspecimens